MedTrace Logo

Virtual E-health System for Implantable Cardioverter Defibrillators

NCT03405740 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1115

Last updated 2026-05-12

No results posted yet for this study

Summary

This is a Canadian multicenter randomized controlled trial to assess remote patient management. Patients will be randomized to remote patient management with VIRTUES versus usual care, and will be stratified by RemoteView vs no RemoteView utilization, as well as by center.

Conditions

  • Cardiac Arrhythmia

Interventions

DEVICE

Remote Patient Management

1. Transmissions will occur at six monthly intervals, with no in-clinic visits. If there is an actionable event on the remote transmission, patients will be seen at their closest community clinic. 2. All patients will be required to follow up with their family physician at least annually, and their cardiologist at least every 2 years. 3. Patients will be contacted by phone at 6 months and 12 months to document their current health status (change in cardiovascular medications, any cardiovascular hospitalizations, in-clinic device checks, or any new cardiovascular testing completed since the last visit) 4. VIRTUES access

DEVICE

Standard of Care

No intervention

Sponsors & Collaborators

  • Cardiac Arrhythmia Network of Canada

    collaborator OTHER

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Medtronic

    collaborator INDUSTRY

  • Ratika Parkash

    lead OTHER

Principal Investigators

  • Ratika Parkash, MD FRCPC · Nova Scotia Health Authority

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2026-05-01
Completion
2026-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03405740 on ClinicalTrials.gov